Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
780
Zitationen
21
Autoren
2016
Jahr
Abstract
Although the results fall just short of the specified noninferiority margin, the omission of bleomycin from the ABVD regimen after negative findings on interim PET resulted in a lower incidence of pulmonary toxic effects than with continued ABVD but not significantly lower efficacy. (Funded by Cancer Research UK and Others; ClinicalTrials.gov number, NCT00678327.).
Ähnliche Arbeiten
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
2012 · 18.334 Zit.
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
1997 · 11.414 Zit.
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
2000 · 9.917 Zit.
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
1977 · 8.398 Zit.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 · 7.750 Zit.
Autoren
- Peter Johnson
- Massimo Federico
- Amy A. Kirkwood
- Alexander Fosså
- Leanne Berkahn
- Angelo Michele Carella
- Francesco d’Amore
- Gunilla Enblad
- Antonella Franceschetto
- Michael Fulham
- Stefano Luminari
- Michael O'Doherty
- Pip Patrick
- Thomas A. Roberts
- Gamal Sidra
- Lindsey Stevens
- Paul Smith
- Judith Trotman
- Zaid Viney
- John Radford
- Sally F. Barrington